The simple summary here is an OK product with continuously poor management / governance. Unfortunately it doesn't matter how good the former is, because the latter will always outweigh...
- Forums
- ASX - By Stock
- BVS
- Ann: Strategic Review Progress, Business Update and FY23 Guidance
BVS
bravura solutions limited.
Add to My Watchlist
0.22%
!
$2.25

Ann: Strategic Review Progress, Business Update and FY23 Guidance, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.25 |
Change
0.005(0.22%) |
Mkt cap ! $1.006B |
Open | High | Low | Value | Volume |
$2.22 | $2.30 | $2.20 | $1.440M | 642.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 5733 | $2.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.25 | 94720 | 37 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 6061 | 2.240 |
13 | 13463 | 2.230 |
8 | 26955 | 2.220 |
7 | 56144 | 2.210 |
8 | 24774 | 2.200 |
Price($) | Vol. | No. |
---|---|---|
2.250 | 92989 | 34 |
2.260 | 41970 | 16 |
2.270 | 45964 | 8 |
2.280 | 9672 | 5 |
2.290 | 167627 | 4 |
Last trade - 15.21pm 18/06/2025 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online